Status:
RECRUITING
Detection of Genetic Markers of Lung Cancer
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
Detailed Description
The multistage theory of carcinogenesis includes the development of multiple activating genetic changes due to exposure to carcinogens, either primarily, or superimposed upon pre-existing mutations in...
Eligibility Criteria
Inclusion
- Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy
- Written informed consent.
- To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass
Exclusion
- None
Key Trial Info
Start Date :
June 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2050
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT00280202
Start Date
June 1 1996
End Date
December 1 2050
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillman Cancer Center
Pittsburgh, Pennsylvania, United States, 15232